GRIFOLS | GRF - Loan Capital


GRIFOLS reported EUR7.17B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Alcon AG USD 4.16B 434M Mar/2026
Almirall EUR 303.77M 21.04M Jun/2026
Amadeus IT EUR 2.54B 2.2M Jun/2026
argenx SE USD 36M 432K Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Bayer EUR 30.68B 1.15B Mar/2026
Cie Automotive EUR 1.48B 58.65M Dec/2025
Demant DKK 18.98B 3.71B Dec/2025
Ence Energia y Celulosa EUR 491M 18.58M Mar/2026
Essilor EUR 9.66B 190M Jun/2026
Ferrovial EUR 10.04B 680M Jun/2026
Fresenius EUR 9.55B 1.24B Jun/2026
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Genmab DKK 4.96B 28M Jun/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GRIFOLS EUR 7.17B 1.91B Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Inditex EUR 4.44B 45M Mar/2026
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.49B 42M Jun/2026
Philips EUR 6.32B 575M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
Smith & Nephew USD 3.21B 85M Jun/2026
UCB EUR 2.18B 634M Dec/2025
Viscofan EUR 68M 172K Jun/2026